Empagliflozin Is Not Renoprotective in Non-Diabetic Rat Models of Chronic Kidney Disease

Gliflozins (sodium-glucose transporter-2 inhibitors) exhibited renoprotective effects not only in diabetic but also in non-diabetic patients with chronic kidney disease (CKD). Controversial results were reported in experimental non-diabetic models of CKD. Therefore, we examined empagliflozin effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Hojná, Silvie, Kotsaridou, Zoe, Vaňourková, Zdeňka, Rauchová, Hana, Behuliak, Michal, Kujal, Petr, Kadlecová, Michaela, Zicha, Josef, Vaněčková, Ivana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599022/
https://www.ncbi.nlm.nih.gov/pubmed/36289772
http://dx.doi.org/10.3390/biomedicines10102509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599022/
https://www.ncbi.nlm.nih.gov/pubmed/36289772
http://dx.doi.org/10.3390/biomedicines10102509

Ejemplares similares